PEG-3, a nontransforming cancer progression gene, is a positive regulator of cancer aggressiveness and angiogenesis
about
Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesisDeveloping an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinicGadd34 functional domains involved in growth suppression and apoptosisTargeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter.Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice.Molecular markers and determinants of prostate cancer metastasis.PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogen-activated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells.Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV).Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.A novel statistical approach for identification of the master regulator transcription factor.Ionizing radiation enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human ovarian cancer.The endoplasmic reticulum stress marker CHOP predicts survival in malignant mesothelioma.Selected approaches for rational drug design and high throughput screening to identify anti-cancer moleculesWeSME: uncovering mutual exclusivity of cancer drivers and beyond.Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis.The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells.Cooperation between AP1 and PEA3 sites within the progression elevated gene-3 (PEG-3) promoter regulate basal and differential expression of PEG-3 during progression of the oncogenic phenotype in transformed rat embryo cells.Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways.Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.Progression elevated gene-3, PEG-3, induces genomic instability in rodent and human tumor cells.A cancer terminator virus eradicates both primary and distant human melanomas.Therapeutic effects of adenovirus-mediated CD and NIS expression combined with Na131I/5-FC on human thyroid cancer.
P2860
Q24321673-5723E898-5158-40C2-87FC-1BF91E1EDD3AQ27694606-EC39D855-35BC-4FB9-9336-AA70266BF8BAQ28180042-C5105F42-CDD1-4F45-9A70-3C9429B180E7Q33762359-2520CEF7-90B4-4EE2-9293-D28E9EA9EC04Q34048220-23ACF066-3001-4210-A9EC-4D2E72A476E0Q34465689-6F3261A8-7B4F-45A9-9B12-AC74946E71A0Q35092834-D1A2AE9B-017E-4634-B3F7-298FDC1390E8Q35095082-9A596D57-71EF-4ED5-9D81-9CCEBA9254BDQ35154868-972C8950-87C2-40D3-84BD-B5F0D34C5000Q36266718-3C7A7B44-F0D2-4939-9F82-46E3C69DB660Q36387940-13DCF03E-A68A-477D-84A7-297962F2BCF1Q36747341-D1177EE1-6FC3-4972-A04D-57499912FC72Q37149641-3641BFEE-5635-4708-A203-00B1525025AEQ39788196-3FE95B1C-214C-4456-B114-33DAEBAA7409Q40484608-5C612C45-79EE-4544-8D8A-26920AD0F5E5Q40659392-F45AE57D-A1C0-434A-8259-8B4FE1B6CCB7Q40865275-758D7E6A-3A8A-4994-8989-850E0198BE4BQ42506345-52CC97D9-5F23-448F-8333-8FAF0A5E1C86Q43796887-FD70E97D-DFE8-4C4A-9093-A59220F209C4Q44062726-7CBB9C37-5779-4082-97DC-EFBBEFFADD4BQ45396658-09722E24-2B2E-40DE-990B-4B63E7493AA1Q49207200-F1818729-9ECC-4051-9AE3-8C57449D8DCB
P2860
PEG-3, a nontransforming cancer progression gene, is a positive regulator of cancer aggressiveness and angiogenesis
description
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 1999
@ast
im Dezember 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1999/12/21)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/12/21)
@nl
наукова стаття, опублікована в грудні 1999
@uk
name
PEG-3, a nontransforming cance ...... ggressiveness and angiogenesis
@ast
PEG-3, a nontransforming cance ...... ggressiveness and angiogenesis
@en
PEG-3, a nontransforming cance ...... ggressiveness and angiogenesis
@nl
type
label
PEG-3, a nontransforming cance ...... ggressiveness and angiogenesis
@ast
PEG-3, a nontransforming cance ...... ggressiveness and angiogenesis
@en
PEG-3, a nontransforming cance ...... ggressiveness and angiogenesis
@nl
prefLabel
PEG-3, a nontransforming cance ...... ggressiveness and angiogenesis
@ast
PEG-3, a nontransforming cance ...... ggressiveness and angiogenesis
@en
PEG-3, a nontransforming cance ...... ggressiveness and angiogenesis
@nl
P2093
P2860
P356
P1476
PEG-3, a nontransforming cance ...... ggressiveness and angiogenesis
@en
P2093
C. S. Young
G. J. Duigou
M. N. Wang
N. I. Goldstein
P. B. Fisher
P2860
P304
15115–15120
P356
10.1073/PNAS.96.26.15115
P407
P577
1999-12-21T00:00:00Z